search
Back to results

Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants

Primary Purpose

Bacterial Infection, Sepsis, Infant, Newborn

Status
Unknown status
Phase
Phase 3
Locations
Pakistan
Study Type
Interventional
Intervention
ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin
Sponsored by
Aga Khan University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bacterial Infection focused on measuring Neonatal sepsis, Neonatal pneumonia, Bacterial infections, Young infants, Neonate, Community, Developing country

Eligibility Criteria

0 Years - 59 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 0-59 days presenting to Young Infant community study site Clinical diagnosis of possible serious bacterial infection by study physician according to specified clinical criteria Parents refuse to accept referral care and sign (or thumb imprint) document stating this. Parents consent to community centre-based intramuscular antibiotic injections Exclusion Criteria: Age over 59 days Presence of severe jaundice diagnosed clinically or by laboratory investigation (bilirubin > 12 g/dl in term and > 7 in pre-term baby). Presence of obvious meningitis (bulging fontanelle, observed seizures) Patient previously enrolled in antibiotic therapy trial Parents accept hospital referral Parents do not consent to any injectable therapy

Sites / Locations

  • Aga Khan University community field sites

Outcomes

Primary Outcome Measures

The primary outcome of success rate will be defined as patient cured or improved with the regimen assigned to, on day 7 of therapy.

Secondary Outcome Measures

Completion rates
Adverse events
Relapse rates

Full Information

First Posted
September 12, 2005
Last Updated
September 7, 2006
Sponsor
Aga Khan University
search

1. Study Identification

Unique Protocol Identification Number
NCT00189384
Brief Title
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
Official Title
Randomized Controlled Trial of Intramuscular Ceftriaxone Versus Procaine Penicillin Versus Cotrimoxazole and Gentamicin for Management of Serious Bacterial Infections in Young Infants in Community Settings
Study Type
Interventional

2. Study Status

Record Verification Date
September 2006
Overall Recruitment Status
Unknown status
Study Start Date
November 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Aga Khan University

4. Oversight

5. Study Description

Brief Summary
Approximately one-third of neonatal deaths in developing countries are due to infections acquired through the birth canal and/or exposure to an unclean environment soon after birth. Current World Health Organization recommendations for the management of infants younger than 2 months of age who have serious bacterial infections involve hospitalization and parenteral therapy for at least 10 days with antibiotic regimens containing penicillin or ampicillin combined with an aminoglycoside.However, in many settings throughout the developing world, this is not currently possible, nor is this standard of care likely to be feasible in the near future. Several studies have reported that for a variety of sociocultural reasons many families are unable or unwilling to access hospital-based care and their sick young infants do not get hospitalized, and instead, receive a variety of home-based antibiotic therapies, or none at all. In our community field sites, approximately 70% of families refuse hospital referral for a sick newborn, despite provision of transport. Thus, there is an urgent need to define the role of community/first-level facility-based care versus hospitalization for the management of young infants with serious bacterial infections, and the potential for community-based parenteral antibiotics as an alternative strategy in resource poor areas with high neonatal mortality rates. Bang and colleagues have demonstrated significant reductions in neonatal mortality from infections in an underdeveloped rural district in Maharashtra, India by a field-based case management approach which used oral cotrimoxazole and intramuscular gentamicin given for 7 days as treatment for neonates with sepsis. This study is an equivalence randomized controlled trial (RCT) comparing once daily IM ceftriaxone injection to once daily IM procaine penicillin and gentamicin injection, to once daily intramuscular gentamicin injection and twice daily oral cotrimoxazole, given for 7 days in babies with clinically-diagnosed possible serious bacterial infection (pneumonia, or sepsis with or without local infections such as skin or umbilical infections) whose families refused referral to a hospital. After supplementary informed consent, patients meeting specific inclusion and exclusion criteria are randomly allocated to one of the three regimens being tested. The study hypothesis is that all 3 regimens will perform equally well in the treatment of sepsis in a first-level facility setting.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bacterial Infection, Sepsis, Infant, Newborn
Keywords
Neonatal sepsis, Neonatal pneumonia, Bacterial infections, Young infants, Neonate, Community, Developing country

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
426 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin
Primary Outcome Measure Information:
Title
The primary outcome of success rate will be defined as patient cured or improved with the regimen assigned to, on day 7 of therapy.
Secondary Outcome Measure Information:
Title
Completion rates
Title
Adverse events
Title
Relapse rates

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Years
Maximum Age & Unit of Time
59 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 0-59 days presenting to Young Infant community study site Clinical diagnosis of possible serious bacterial infection by study physician according to specified clinical criteria Parents refuse to accept referral care and sign (or thumb imprint) document stating this. Parents consent to community centre-based intramuscular antibiotic injections Exclusion Criteria: Age over 59 days Presence of severe jaundice diagnosed clinically or by laboratory investigation (bilirubin > 12 g/dl in term and > 7 in pre-term baby). Presence of obvious meningitis (bulging fontanelle, observed seizures) Patient previously enrolled in antibiotic therapy trial Parents accept hospital referral Parents do not consent to any injectable therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anita KM Zaidi, MBBS, SM
Organizational Affiliation
Department of Pediatrics, Aga Khan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aga Khan University community field sites
City
Karachi
State/Province
Sindh
ZIP/Postal Code
74800
Country
Pakistan

12. IPD Sharing Statement

Citations:
PubMed Identifier
10622298
Citation
Bang AT, Bang RA, Baitule SB, Reddy MH, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet. 1999 Dec 4;354(9194):1955-61. doi: 10.1016/S0140-6736(99)03046-9.
Results Reference
background
PubMed Identifier
15791283
Citation
Bang AT, Reddy HM, Deshmukh MD, Baitule SB, Bang RA. Neonatal and infant mortality in the ten years (1993 to 2003) of the Gadchiroli field trial: effect of home-based neonatal care. J Perinatol. 2005 Mar;25 Suppl 1:S92-107. doi: 10.1038/sj.jp.7211277.
Results Reference
background
PubMed Identifier
15791280
Citation
Bang AT, Bang RA, Stoll BJ, Baitule SB, Reddy HM, Deshmukh MD. Is home-based diagnosis and treatment of neonatal sepsis feasible and effective? Seven years of intervention in the Gadchiroli field trial (1996 to 2003). J Perinatol. 2005 Mar;25 Suppl 1:S62-71. doi: 10.1038/sj.jp.7211273.
Results Reference
background

Learn more about this trial

Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants

We'll reach out to this number within 24 hrs